• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Influence of plasma exchange pheresis on plasma elimination of ceftriaxone.血浆置换疗法对头孢曲松血浆清除率的影响。
Antimicrob Agents Chemother. 1990 Jun;34(6):1276-7. doi: 10.1128/AAC.34.6.1276.
2
Influence of therapeutic plasmapheresis on elimination of ceftiaxone.治疗性血浆置换对头孢噻肟清除的影响。
Antimicrob Agents Chemother. 1993 May;37(5):1171-3. doi: 10.1128/AAC.37.5.1171.
3
Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.头孢曲松在水牛犊牛体内的药代动力学及给药方案
Vet Res Commun. 2004 May;28(4):331-8. doi: 10.1023/b:verc.0000026658.45361.ce.
4
Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model.艾曲泊帕治疗剂量在健康志愿者中不抑制肝脏BCRP：以静脉注射头孢曲松为模型
J Pharm Pharm Sci. 2018;21(1):236-246. doi: 10.18433/jpps29856.
5
[Pharmacokinetics of ceftriaxone in hemodialysis].
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):719-23.
6
Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats.老年大鼠单独使用头孢曲松与联合丹红注射液的药代动力学特征比较
Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):505-517. doi: 10.1007/s13318-018-0530-6.
7
Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.头孢曲松在中国成年人中的临床药代动力学与治疗效果
Chemotherapy. 1997 May-Jun;43(3):218-26. doi: 10.1159/000239567.
8
Pharmacokinetics of ceftriaxone in patients with typhoid fever.伤寒患者中头孢曲松的药代动力学
Antimicrob Agents Chemother. 1994 Oct;38(10):2415-8. doi: 10.1128/AAC.38.10.2415.
9
Ceftriaxone pharmacokinetics during continuous arteriovenous haemofiltration.连续动静脉血液滤过期间头孢曲松的药代动力学
J Antimicrob Chemother. 1991 Mar;27(3):394-6. doi: 10.1093/jac/27.3.394.
10
Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camels (Camelus Dromedarius).头孢曲松在骆驼（单峰驼）单次静脉注射和肌肉注射后的药代动力学参数。
Res Vet Sci. 2008 Jun;84(3):483-9. doi: 10.1016/j.rvsc.2007.07.005. Epub 2007 Sep 4.

引用本文的文献

1
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.头孢曲松和头孢噻肟在标准剂量方案治疗的人类志愿者中的肠道微生物群中具有相似的作用。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02244-18. Print 2019 Jun.
2
Models of antimicrobial pressure on intestinal bacteria of the treated host populations.经治疗宿主群体肠道细菌的抗菌压力模型。
Epidemiol Infect. 2017 Jul;145(10):2081-2094. doi: 10.1017/S095026881700084X. Epub 2017 May 2.
3
Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle.牛肠道共生大肠杆菌中质粒介导的头孢噻呋耐药性的数学模型。
PLoS One. 2012;7(5):e36738. doi: 10.1371/journal.pone.0036738. Epub 2012 May 16.
4
Influence of therapeutic plasmapheresis on elimination of ceftiaxone.治疗性血浆置换对头孢噻肟清除的影响。
Antimicrob Agents Chemother. 1993 May;37(5):1171-3. doi: 10.1128/AAC.37.5.1171.

本文引用的文献

1
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.浓度依赖性血浆蛋白结合对头孢曲松动力学的影响。
Clin Pharmacol Ther. 1981 May;29(5):650-7. doi: 10.1038/clpt.1981.90.
2
Ceftriaxone: renal and biliary excretion and effect on the colon microflora.头孢曲松：肾脏和胆汁排泄及对结肠微生物群的影响。
J Antimicrob Chemother. 1982 Sep;10(3):207-15. doi: 10.1093/jac/10.3.207.
3
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.
Ann Neurol. 1988 Apr;23(4):347-53. doi: 10.1002/ana.410230406.
4
Kinetics of ceftazidime during plasmapheresis.
Eur J Clin Pharmacol. 1987;33(2):197-201. doi: 10.1007/BF00544567.
5
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估，以及关于其治疗用途的最新情况，特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.

血浆置换疗法对头孢曲松血浆清除率的影响。

Influence of plasma exchange pheresis on plasma elimination of ceftriaxone.

作者信息

Bakken J S, Cavalieri S J, Gangeness D

机构信息

Department of Infectious Diseases, Duluth Clinic, Minnesota.

出版信息

Antimicrob Agents Chemother. 1990 Jun;34(6):1276-7. doi: 10.1128/AAC.34.6.1276.

DOI:10.1128/AAC.34.6.1276
PMID:2393290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171801/
Abstract

The plasma elimination rates of serial 2-g intravenous injections of ceftriaxone were studied in a patient who also was treated with therapeutic plasma exchange pheresis. Plasmapheresis had negligible influence on the total clearance of ceftriaxone.

摘要

在一名同时接受治疗性血浆置换疗法的患者中，研究了连续静脉注射2克头孢曲松后的血浆清除率。血浆置换对头孢曲松的总清除率影响可忽略不计。